{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:13:03Z","timestamp":1780337583255,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00417-020-05032-9","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T21:14:59Z","timestamp":1610054099000},"page":"1273-1280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Changes in choroidal imaging parameters following adalimumab therapy for refractory noninfectious uveitis"],"prefix":"10.1007","volume":"259","author":[{"given":"Ryuto","family":"Nishisho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6458-539X","authenticated-orcid":false,"given":"Sentaro","family":"Kusuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Sotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Katsuyama-Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Matsumiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Morinobu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"issue":"10","key":"5032_CR1","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1509852","volume":"375","author":"GJ Jaffe","year":"2016","unstructured":"Jaffe GJ, Dick AD, Brezin AP, Nguyen QD, Thorne JE, Kestelyn P, Barisani-Asenbauer T, Franco P, Heiligenhaus A, Scales D, Chu DS, Camez A, Kwatra NV, Song AP, Kron M, Tari S, Suhler EB (2016) Adalimumab in patients with active noninfectious uveitis. N Engl J Med 375(10):932\u2013943. https:\/\/doi.org\/10.1056\/NEJMoa1509852","journal-title":"N Engl J Med"},{"issue":"10050","key":"5032_CR2","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/s0140-6736(16)31339-3","volume":"388","author":"QD Nguyen","year":"2016","unstructured":"Nguyen QD, Merrill PT, Jaffe GJ, Dick AD, Kurup SK, Sheppard J, Schlaen A, Pavesio C, Cimino L, Van Calster J, Camez AA, Kwatra NV, Song AP, Kron M, Tari S, Br\u00e9zin AP (2016) Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet 388(10050):1183\u20131192. https:\/\/doi.org\/10.1016\/s0140-6736(16)31339-3","journal-title":"Lancet"},{"issue":"7","key":"5032_CR3","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.ophtha.2017.12.039","volume":"125","author":"EB Suhler","year":"2018","unstructured":"Suhler EB, Adan A, Brezin AP, Fortin E, Goto H, Jaffe GJ, Kaburaki T, Kramer M, Lim LL, Muccioli C, Nguyen QD, Van Calster J, Cimino L, Kron M, Song AP, Liu J, Pathai S, Camez A, Schlaen A, van Velthoven MEJ, Vitale AT, Zierhut M, Tari S, Dick AD (2018) Safety and efficacy of Adalimumab in patients with noninfectious uveitis in an ongoing open-label study: VISUAL III. Ophthalmology 125(7):1075\u20131087. https:\/\/doi.org\/10.1016\/j.ophtha.2017.12.039","journal-title":"Ophthalmology"},{"issue":"3","key":"5032_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140(3):509\u2013516. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"5032_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jcjo.2019.06.005","volume":"55","author":"GG Deak","year":"2020","unstructured":"Deak GG, Zhou M, Sporysheva A, Goldstein DA (2020) Novel imaging modalities in patients with uveitis. Can J Ophthalmol 55(1):20\u201329. https:\/\/doi.org\/10.1016\/j.jcjo.2019.06.005","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"5032_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","volume":"29","author":"DL Nickla","year":"2010","unstructured":"Nickla DL, Wallman J (2010) The multifunctional choroid. Prog Retin Eye Res 29(2):144\u2013168. https:\/\/doi.org\/10.1016\/j.preteyeres.2009.12.002","journal-title":"Prog Retin Eye Res"},{"key":"5032_CR7","doi-asserted-by":"publisher","first-page":"100797","DOI":"10.1016\/j.preteyeres.2019.100797","volume":"75","author":"F Pichi","year":"2020","unstructured":"Pichi F, Invernizzi A, Tucker WR, Munk MR (2020) Optical coherence tomography diagnostic signs in posterior uveitis. Prog Retin Eye Res 75:100797. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.100797","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"5032_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ajo.2008.05.032","volume":"146","author":"RF Spaide","year":"2008","unstructured":"Spaide RF, Koizumi H, Pozzoni MC (2008) Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 146(4):496\u2013500. https:\/\/doi.org\/10.1016\/j.ajo.2008.05.032","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"5032_CR9","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.ophtha.2014.02.023","volume":"121","author":"G Staurenghi","year":"2014","unstructured":"Staurenghi G, Sadda S, Chakravarthy U, Spaide RF, International Nomenclature for Optical Coherence Tomography Panel (2014) Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: the IN*OCT consensus. Ophthalmology 121(8):1572\u20131578. https:\/\/doi.org\/10.1016\/j.ophtha.2014.02.023","journal-title":"Ophthalmology"},{"issue":"7","key":"5032_CR10","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00417-011-1910-7","volume":"250","author":"K Nakai","year":"2012","unstructured":"Nakai K, Gomi F, Ikuno Y, Yasuno Y, Nouchi T, Ohguro N, Nishida K (2012) Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 250(7):1089\u20131095. https:\/\/doi.org\/10.1007\/s00417-011-1910-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"5032_CR11","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s00417-013-2334-3","volume":"251","author":"D Goldenberg","year":"2013","unstructured":"Goldenberg D, Goldstein M, Loewenstein A, Habot-Wilner Z (2013) Vitreal, retinal, and choroidal findings in active and scarred toxoplasmosis lesions: a prospective study by spectral-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 251(8):2037\u20132045. https:\/\/doi.org\/10.1007\/s00417-013-2334-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"5032_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/IAE.0000000000000312","volume":"35","author":"A Invernizzi","year":"2015","unstructured":"Invernizzi A, Mapelli C, Viola F, Cigada M, Cimino L, Ratiglia R, Staurenghi G, Gupta A (2015) Choroidal granulomas visualized by enhanced depth imaging optical coherence tomography. Retina 35(3):525\u2013531. https:\/\/doi.org\/10.1097\/IAE.0000000000000312","journal-title":"Retina"},{"issue":"1","key":"5032_CR13","doi-asserted-by":"publisher","first-page":"e0146344","DOI":"10.1371\/journal.pone.0146344","volume":"11","author":"R Agrawal","year":"2016","unstructured":"Agrawal R, Salman M, Tan KA, Karampelas M, Sim DA, Keane PA, Pavesio C (2016) Choroidal vascularity index (CVI)--a novel optical coherence tomography parameter for monitoring patients with Panuveitis? PLoS One 11(1):e0146344. https:\/\/doi.org\/10.1371\/journal.pone.0146344","journal-title":"PLoS One"},{"issue":"12","key":"5032_CR14","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1136\/bjophthalmol-2015-307734","volume":"100","author":"M Egawa","year":"2016","unstructured":"Egawa M, Mitamura Y, Akaiwa K, Semba K, Kinoshita T, Uchino E, Sonoda S, Sakamoto T (2016) Changes of choroidal structure after corticosteroid treatment in eyes with Vogt-Koyanagi-Harada disease. Br J Ophthalmol 100(12):1646\u20131650. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307734","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"5032_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00417-016-3283-4","volume":"254","author":"H Kawano","year":"2016","unstructured":"Kawano H, Sonoda S, Yamashita T, Maruko I, Iida T, Sakamoto T (2016) Relative changes in luminal and stromal areas of choroid determined by binarization of EDI-OCT images in eyes with Vogt-Koyanagi-Harada disease after treatment. Graefes Arch Clin Exp Ophthalmol 254(3):421\u2013426. https:\/\/doi.org\/10.1007\/s00417-016-3283-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"5032_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/bjophthalmol-2014-306439","volume":"100","author":"Y Tagawa","year":"2016","unstructured":"Tagawa Y, Namba K, Mizuuchi K, Takemoto Y, Iwata D, Uno T, Fukuhara T, Hirooka K, Kitaichi N, Ohno S, Ishida S (2016) Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol 100(4):473\u2013477. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-306439","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"5032_CR17","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/eye.2017.54","volume":"31","author":"N Skvortsova","year":"2017","unstructured":"Skvortsova N, Gasc A, Jeannin B, Herbort CP (2017) Evolution of choroidal thickness over time and effect of early and sustained therapy in birdshot retinochoroiditis. Eye (Lond) 31(8):1205\u20131211. https:\/\/doi.org\/10.1038\/eye.2017.54","journal-title":"Eye (Lond)"},{"issue":"8697","key":"5032_CR18","first-page":"1078","volume":"335","author":"No authors listed","year":"1990","unstructured":"No authors listed (1990) Criteria for diagnosis of Behcet\u2019s disease. International Study Group for Behcet\u2019s Disease 367. Lancet 335(8697):1078\u20131080","journal-title":"Lancet"},{"issue":"5","key":"5032_CR19","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/s0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131(5):647\u2013652. https:\/\/doi.org\/10.1016\/s0002-9394(01)00925-4","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"5032_CR20","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s10384-012-0158-z","volume":"56","author":"N Ohguro","year":"2012","unstructured":"Ohguro N, Sonoda KH, Takeuchi M, Matsumura M, Mochizuki M (2012) The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol 56(5):432\u2013435. https:\/\/doi.org\/10.1007\/s10384-012-0158-z","journal-title":"Jpn J Ophthalmol"},{"issue":"10","key":"5032_CR21","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","volume":"103","author":"M Mochizuki","year":"2019","unstructured":"Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharya NR, Rao NA, International Workshop on Ocular Sarcoidosis Study Group (2019) Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol 103(10):1418\u20131422. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313356","journal-title":"Br J Ophthalmol"},{"key":"5032_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ajo.2016.05.013","volume":"168","author":"AR Fox","year":"2016","unstructured":"Fox AR, Gordon LK, Heckenlively JR, Davis JL, Goldstein DA, Lowder CY, Nussenblatt RB, Butler NJ, Dalal M, Jayasundera T, Smith WM, Lee RW, Adamus G, Chan CC, Hooks JJ, Morgans CW, Detrick B, Sen HN (2016) Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified Delphi approach. Am J Ophthalmol 168:183\u2013190. https:\/\/doi.org\/10.1016\/j.ajo.2016.05.013","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"5032_CR23","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.ajo.2015.03.005","volume":"159","author":"S Sonoda","year":"2015","unstructured":"Sonoda S, Sakamoto T, Yamashita T, Uchino E, Kawano H, Yoshihara N, Terasaki H, Shirasawa M, Tomita M, Ishibashi T (2015) Luminal and stromal areas of choroid determined by binarization method of optical coherence tomographic images. Am J Ophthalmol 159(6):1123\u20131131 e1121. https:\/\/doi.org\/10.1016\/j.ajo.2015.03.005","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"5032_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/s0161-6420(85)34001-0","volume":"92","author":"RB Nussenblatt","year":"1985","unstructured":"Nussenblatt RB, Palestine AG, Chan CC, Roberge F (1985) Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 92(4):467\u2013471. https:\/\/doi.org\/10.1016\/s0161-6420(85)34001-0","journal-title":"Ophthalmology"},{"issue":"1","key":"5032_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","volume":"26","author":"T Tsirouki","year":"2018","unstructured":"Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C, Androudi S (2018) A focus on the epidemiology of uveitis. Ocul Immunol Inflamm 26(1):2\u201316. https:\/\/doi.org\/10.1080\/09273948.2016.1196713","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"5032_CR26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ophtha.2019.08.031","volume":"127","author":"A Al-Janabi","year":"2020","unstructured":"Al-Janabi A, El Nokrashy A, Sharief L, Nagendran V, Lightman S, Tomkins-Netzer O (2020) Long-term outcomes of treatment with biological agents in eyes with refractory, active, noninfectious intermediate uveitis, posterior uveitis, or Panuveitis. Ophthalmology 127(3):410\u2013416. https:\/\/doi.org\/10.1016\/j.ophtha.2019.08.031","journal-title":"Ophthalmology"},{"issue":"3","key":"5032_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.survophthal.2018.11.002","volume":"64","author":"SR Singh","year":"2019","unstructured":"Singh SR, Vupparaboina KK, Goud A, Dansingani KK, Chhablani J (2019) Choroidal imaging biomarkers. Surv Ophthalmol 64(3):312\u2013333. https:\/\/doi.org\/10.1016\/j.survophthal.2018.11.002","journal-title":"Surv Ophthalmol"},{"key":"5032_CR28","doi-asserted-by":"publisher","unstructured":"Pirani V, Pelliccioni P, De Turris S, Rosati A, Franceschi A, Pasanisi P, Gesuita R, Nicolai M, Mariotti C (2020) Intraocular inflammation control and changes in retinal and choroidal architecture in refractory non-infectious uveitis patients after adalimumab therapy. J Clin Med 9(2). https:\/\/doi.org\/10.3390\/jcm9020510","DOI":"10.3390\/jcm9020510"},{"issue":"3","key":"5032_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/IAE.0b013e3181eef053","volume":"31","author":"I Maruko","year":"2011","unstructured":"Maruko I, Iida T, Sugano Y, Oyamada H, Sekiryu T, Fujiwara T, Spaide RF (2011) Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina 31(3):510\u2013517. https:\/\/doi.org\/10.1097\/IAE.0b013e3181eef053","journal-title":"Retina"},{"issue":"10","key":"5032_CR30","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1097\/IAE.0b013e318256205a","volume":"32","author":"M Nakayama","year":"2012","unstructured":"Nakayama M, Keino H, Okada AA, Watanabe T, Taki W, Inoue M, Hirakata A (2012) Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease. Retina 32(10):2061\u20132069. https:\/\/doi.org\/10.1097\/IAE.0b013e318256205a","journal-title":"Retina"},{"issue":"1","key":"5032_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/bjophthalmol-2012-302089","volume":"97","author":"FT da Silva","year":"2013","unstructured":"da Silva FT, Sakata VM, Nakashima A, Hirata CE, Olivalves E, Takahashi WY, Costa RA, Yamamoto JH (2013) Enhanced depth imaging optical coherence tomography in long-standing Vogt-Koyanagi-Harada disease. Br J Ophthalmol 97(1):70\u201374. https:\/\/doi.org\/10.1136\/bjophthalmol-2012-302089","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"5032_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/tvst.5.4.7","volume":"5","author":"R Agrawal","year":"2016","unstructured":"Agrawal R, Li LK, Nakhate V, Khandelwal N, Mahendradas P (2016) Choroidal vascularity index in Vogt-Koyanagi-Harada disease: an EDI-OCT derived tool for monitoring disease progression. Transl Vis Sci Technol 5(4):7. https:\/\/doi.org\/10.1167\/tvst.5.4.7","journal-title":"Transl Vis Sci Technol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-05032-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-020-05032-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-05032-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T04:15:12Z","timestamp":1620274512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-020-05032-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["5032"],"URL":"https:\/\/doi.org\/10.1007\/s00417-020-05032-9","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"31 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review board (Kobe University Graduate School of Medicine) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Subject\u2019s informed consent was not required since this was a retrospective review.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}